Corticosteroid-induced hyperglycemia is a common medical problem which can cause frequent hospitalizations
and therefore relates to an increase in morbidity. Metformin, sulfonylureas, thiazolidinediones and insulin are well known
available therapies for the treatment of steroid induced hyperglycemia.
Incretin based therapies are a newly developing strategies with a considerable importance in the treatment regimen as
well. This review aims at discussing the pathophysiology of steroid induced hyperglycemia in addition to the available
therapies used for treatment, focusing on incretin therapies.